Cargando…

Dl-3-n-Butylphthalide Exerts Dopaminergic Neuroprotection Through Inhibition of Neuroinflammation

Microglia-mediated neuroinflammation contributes to multiple neurodegenerative disorders, including PD. Therefore, the regulation of microglial activation probably has the therapeutic potential. This study is aimed to determine whether NBP could suppress microglial activation and protect dopaminergi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yajing, Wu, Tingting, Li, Heng, Li, Xuan, Li, Qing, Zhu, Xiaoying, Yu, Mei, Kuo, Sheng-Han, Huang, Fang, Wu, Yun-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403182/
https://www.ncbi.nlm.nih.gov/pubmed/30873019
http://dx.doi.org/10.3389/fnagi.2019.00044
_version_ 1783400532870692864
author Chen, Yajing
Wu, Tingting
Li, Heng
Li, Xuan
Li, Qing
Zhu, Xiaoying
Yu, Mei
Kuo, Sheng-Han
Huang, Fang
Wu, Yun-Cheng
author_facet Chen, Yajing
Wu, Tingting
Li, Heng
Li, Xuan
Li, Qing
Zhu, Xiaoying
Yu, Mei
Kuo, Sheng-Han
Huang, Fang
Wu, Yun-Cheng
author_sort Chen, Yajing
collection PubMed
description Microglia-mediated neuroinflammation contributes to multiple neurodegenerative disorders, including PD. Therefore, the regulation of microglial activation probably has the therapeutic potential. This study is aimed to determine whether NBP could suppress microglial activation and protect dopaminergic neurons from excessive neuroinflammation. In the present study, MPTP-induced PD model was established to explore the neuroprotective and anti-inflammatory effect of NBP. We assessed motor deficits, dopaminergic neurodegeneration and microglial activation in PD mice. In vitro, the anti-inflammatory activity of NBP was confirmed by cell viability assay of SH-SY5Y cells after being treated with conditioned medium from LPS-stimulated BV-2 cells and from 1-Methyl-4-phenylpyridinium iodide (MPP(+))-stimulated BV-2 cells. The expression of pro-inflammatory molecules was determined by RT-PCR, Western Blot and ELISA assay. The generation of NO and ROS were also assessed. The involvement of signaling pathways such as MAPK, NF-κB, and PI3k/Akt were further investigated by Western Blot and immunofluorescence assay. The neuroprotective effect of NBP was demonstrated in vivo as shown by the improvement of dopaminergic neurodegeneration, motor deficits and microglial activation in MPTP-induced mouse model of PD. The expression of pro-inflammatory mediators was also reduced by NBP administration. In vitro, NBP also protected dopaminergic neurons from neurotoxicity induced by activated microglia. NBP pretreatment not only reduced pro-inflammatory molecules, but also suppressed NO release and ROS generation in BV-2 cells. Further mechanism research suggested that the inactivation of MAPK, NF-κB and PI3K/Akt may involve in anti-neuroinflammation role of NBP. In conclusion, our results revealed that NBP exerted dopaminergic neuroprotection through inhibition of microglia-mediated neuroinflammation, suggesting the promising therapeutic effect of NBP for PD.
format Online
Article
Text
id pubmed-6403182
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-64031822019-03-14 Dl-3-n-Butylphthalide Exerts Dopaminergic Neuroprotection Through Inhibition of Neuroinflammation Chen, Yajing Wu, Tingting Li, Heng Li, Xuan Li, Qing Zhu, Xiaoying Yu, Mei Kuo, Sheng-Han Huang, Fang Wu, Yun-Cheng Front Aging Neurosci Neuroscience Microglia-mediated neuroinflammation contributes to multiple neurodegenerative disorders, including PD. Therefore, the regulation of microglial activation probably has the therapeutic potential. This study is aimed to determine whether NBP could suppress microglial activation and protect dopaminergic neurons from excessive neuroinflammation. In the present study, MPTP-induced PD model was established to explore the neuroprotective and anti-inflammatory effect of NBP. We assessed motor deficits, dopaminergic neurodegeneration and microglial activation in PD mice. In vitro, the anti-inflammatory activity of NBP was confirmed by cell viability assay of SH-SY5Y cells after being treated with conditioned medium from LPS-stimulated BV-2 cells and from 1-Methyl-4-phenylpyridinium iodide (MPP(+))-stimulated BV-2 cells. The expression of pro-inflammatory molecules was determined by RT-PCR, Western Blot and ELISA assay. The generation of NO and ROS were also assessed. The involvement of signaling pathways such as MAPK, NF-κB, and PI3k/Akt were further investigated by Western Blot and immunofluorescence assay. The neuroprotective effect of NBP was demonstrated in vivo as shown by the improvement of dopaminergic neurodegeneration, motor deficits and microglial activation in MPTP-induced mouse model of PD. The expression of pro-inflammatory mediators was also reduced by NBP administration. In vitro, NBP also protected dopaminergic neurons from neurotoxicity induced by activated microglia. NBP pretreatment not only reduced pro-inflammatory molecules, but also suppressed NO release and ROS generation in BV-2 cells. Further mechanism research suggested that the inactivation of MAPK, NF-κB and PI3K/Akt may involve in anti-neuroinflammation role of NBP. In conclusion, our results revealed that NBP exerted dopaminergic neuroprotection through inhibition of microglia-mediated neuroinflammation, suggesting the promising therapeutic effect of NBP for PD. Frontiers Media S.A. 2019-02-28 /pmc/articles/PMC6403182/ /pubmed/30873019 http://dx.doi.org/10.3389/fnagi.2019.00044 Text en Copyright © 2019 Chen, Wu, Li, Li, Li, Zhu, Yu, Kuo, Huang and Wu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Chen, Yajing
Wu, Tingting
Li, Heng
Li, Xuan
Li, Qing
Zhu, Xiaoying
Yu, Mei
Kuo, Sheng-Han
Huang, Fang
Wu, Yun-Cheng
Dl-3-n-Butylphthalide Exerts Dopaminergic Neuroprotection Through Inhibition of Neuroinflammation
title Dl-3-n-Butylphthalide Exerts Dopaminergic Neuroprotection Through Inhibition of Neuroinflammation
title_full Dl-3-n-Butylphthalide Exerts Dopaminergic Neuroprotection Through Inhibition of Neuroinflammation
title_fullStr Dl-3-n-Butylphthalide Exerts Dopaminergic Neuroprotection Through Inhibition of Neuroinflammation
title_full_unstemmed Dl-3-n-Butylphthalide Exerts Dopaminergic Neuroprotection Through Inhibition of Neuroinflammation
title_short Dl-3-n-Butylphthalide Exerts Dopaminergic Neuroprotection Through Inhibition of Neuroinflammation
title_sort dl-3-n-butylphthalide exerts dopaminergic neuroprotection through inhibition of neuroinflammation
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403182/
https://www.ncbi.nlm.nih.gov/pubmed/30873019
http://dx.doi.org/10.3389/fnagi.2019.00044
work_keys_str_mv AT chenyajing dl3nbutylphthalideexertsdopaminergicneuroprotectionthroughinhibitionofneuroinflammation
AT wutingting dl3nbutylphthalideexertsdopaminergicneuroprotectionthroughinhibitionofneuroinflammation
AT liheng dl3nbutylphthalideexertsdopaminergicneuroprotectionthroughinhibitionofneuroinflammation
AT lixuan dl3nbutylphthalideexertsdopaminergicneuroprotectionthroughinhibitionofneuroinflammation
AT liqing dl3nbutylphthalideexertsdopaminergicneuroprotectionthroughinhibitionofneuroinflammation
AT zhuxiaoying dl3nbutylphthalideexertsdopaminergicneuroprotectionthroughinhibitionofneuroinflammation
AT yumei dl3nbutylphthalideexertsdopaminergicneuroprotectionthroughinhibitionofneuroinflammation
AT kuoshenghan dl3nbutylphthalideexertsdopaminergicneuroprotectionthroughinhibitionofneuroinflammation
AT huangfang dl3nbutylphthalideexertsdopaminergicneuroprotectionthroughinhibitionofneuroinflammation
AT wuyuncheng dl3nbutylphthalideexertsdopaminergicneuroprotectionthroughinhibitionofneuroinflammation